50% OFF
MarketBeat All Access
Get 30 days free. Save 50% your first year.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
S&P 500   3,693.23
DOW   29,590.41
QQQ   275.51
Become an Ethical Hacking and Cybercrime Expert
New Shift Could Soon Affect All Americans (Ad)pixel
Will Wall Street's Enthusiasm About Datadog Lead To Big Gains?
MarketBeat: Week in Review 9/19 – 9/23
How You Should Be Choosing Your Stocks (Ad)pixel
China using civilian ships to enhance navy capability, reach
German leader seeks energy deals, alliances on Gulf trip
How You Should Be Choosing Your Stocks (Ad)pixel
Kim Kardashian culls Dolce & Gabbana archives for Milan show
EXPLAINER: Italian election only part of forming government
S&P 500   3,693.23
DOW   29,590.41
QQQ   275.51
Become an Ethical Hacking and Cybercrime Expert
New Shift Could Soon Affect All Americans (Ad)pixel
Will Wall Street's Enthusiasm About Datadog Lead To Big Gains?
MarketBeat: Week in Review 9/19 – 9/23
How You Should Be Choosing Your Stocks (Ad)pixel
China using civilian ships to enhance navy capability, reach
German leader seeks energy deals, alliances on Gulf trip
How You Should Be Choosing Your Stocks (Ad)pixel
Kim Kardashian culls Dolce & Gabbana archives for Milan show
EXPLAINER: Italian election only part of forming government
S&P 500   3,693.23
DOW   29,590.41
QQQ   275.51
Become an Ethical Hacking and Cybercrime Expert
New Shift Could Soon Affect All Americans (Ad)pixel
Will Wall Street's Enthusiasm About Datadog Lead To Big Gains?
MarketBeat: Week in Review 9/19 – 9/23
How You Should Be Choosing Your Stocks (Ad)pixel
China using civilian ships to enhance navy capability, reach
German leader seeks energy deals, alliances on Gulf trip
How You Should Be Choosing Your Stocks (Ad)pixel
Kim Kardashian culls Dolce & Gabbana archives for Milan show
EXPLAINER: Italian election only part of forming government
S&P 500   3,693.23
DOW   29,590.41
QQQ   275.51
Become an Ethical Hacking and Cybercrime Expert
New Shift Could Soon Affect All Americans (Ad)pixel
Will Wall Street's Enthusiasm About Datadog Lead To Big Gains?
MarketBeat: Week in Review 9/19 – 9/23
How You Should Be Choosing Your Stocks (Ad)pixel
China using civilian ships to enhance navy capability, reach
German leader seeks energy deals, alliances on Gulf trip
How You Should Be Choosing Your Stocks (Ad)pixel
Kim Kardashian culls Dolce & Gabbana archives for Milan show
EXPLAINER: Italian election only part of forming government
NASDAQ:MDRX

Allscripts Healthcare Solutions - MDRX Stock Forecast, Price & News

$16.67
-0.03 (-0.18%)
(As of 09/23/2022 12:00 AM ET)
Add
Compare
Today's Range
$16.29
$16.71
50-Day Range
$14.26
$17.65
52-Week Range
$13.05
$23.25
Volume
1.17 million shs
Average Volume
1.22 million shs
Market Capitalization
$1.85 billion
P/E Ratio
38.77
Dividend Yield
N/A
Price Target
$22.00

Allscripts Healthcare Solutions MarketRank™ Forecast

Analyst Rating
Hold
2.33 Rating Score
Upside/​Downside
32.0% Upside
$22.00 Price Target
Short Interest
Healthy
9.31% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.62
Upright™ Environmental Score
News Sentiment
0.73mentions of Allscripts Healthcare Solutions in the last 14 days
Based on 4 Articles This Week
Insider Trading
Selling Shares
$360,569 Sold Last Quarter
Proj. Earnings Growth
7.58%
From $0.66 to $0.71 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.68 out of 5 stars

Medical Sector

95th out of 1,080 stocks

Computer Integrated Systems Design Industry

6th out of 38 stocks

MDRX stock logo

About Allscripts Healthcare Solutions (NASDAQ:MDRX) Stock

Allscripts Healthcare Solutions, Inc., together with its subsidiaries, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions. The company operates through two segments, Hospitals and Large Physician Practices, and Veradigm. The Hospitals and Large Physician Practices segment provides integrated clinical and financial management solutions, which primarily include EHR-related software; and related installation, support and maintenance, outsourcing, private cloud hosting, and revenue cycle management services. The Veradigm segment offers payer and life sciences solutions, which are primarily targeted at payers, life sciences companies, and other healthcare stakeholders; and software applications for patient engagement and EHR software to single-specialty, and small and mid-sized physician practices, including related clinical, financial, administrative, and operational solutions. Its solutions enable clients to transition, analyze, and coordinate care, and enhance the healthcare delivery across the care community. The company serves physicians, hospitals, governments and militaries, health systems, health plans, life-sciences companies, retail clinics, surgery centers, retail pharmacies, pharmacy benefit managers, insurance companies, employer wellness clinics, consumers, lab companies, urgent care facilities, and venture capital firms, as well as post-acute organizations, such as home health and hospice agencies. Allscripts Healthcare Solutions, Inc. was founded in 1986 and is headquartered in Chicago, Illinois.

Receive MDRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Allscripts Healthcare Solutions and its competitors with MarketBeat's FREE daily newsletter.

MDRX Stock News Headlines

Allscripts to Host Virtual Investor Day September 28th
AllScripts: Q2 Earnings Snapshot
Allscripts Announces Second Quarter of 2022 Results
See More Headlines
Receive MDRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Allscripts Healthcare Solutions and its competitors with MarketBeat's FREE daily newsletter.

MDRX Company Calendar

Last Earnings
8/04/2022
Today
9/24/2022
Next Earnings (Estimated)
11/03/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Computer integrated systems design
Sub-Industry
Health Care Technology
Sector
Medical
Current Symbol
NASDAQ:MDRX
CUSIP
01988P10
Employees
8,000
Year Founded
1986

Price Target and Rating

Average Stock Price Forecast
$22.00
High Stock Price Forecast
$26.00
Low Stock Price Forecast
$17.00
Forecasted Upside/Downside
+32.0%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
6 Analysts

Profitability

Net Income
$134.44 million
Pretax Margin
11.84%

Debt

Sales & Book Value

Annual Sales
$1.50 billion
Cash Flow
$2.75 per share
Book Value
$11.49 per share

Miscellaneous

Free Float
108,256,000
Market Cap
$1.85 billion
Optionable
Optionable
Beta
0.98

Social Links


Key Executives

  • Mr. Richard J. PoultonMr. Richard J. Poulton (Age 57)
    CEO & Director
    Comp: $2.45M
  • Ms. Tejal Vakharia (Age 49)
    Sr. VP of Marketing & Gov. Affairs, Gen. Counsel and Chief Compliance Counsel
    Comp: $1.04M
  • Mr. Thomas J. Langan (Age 56)
    Pres & CCO
  • Ms. Leah Jones (Age 50)
    Chief Financial Officer
  • Mr. Joseph R. Rostock (Age 59)
    Sr. VP of Devel. & CTO
  • Jenny Gelinas
    VP of Investor Relations
  • Mr. Richard Elmore
    Sr. VP of Corp. Devel. & Strategy
  • Ms. Rebecca Whaley
    VP of Marketing
  • Ms. Lisa Hammond C.P.C. (Age 50)
    Sr. VP & Chief HR Officer
  • Mr. Paul Lewis
    Sr. VP of Sales & Services and Acting Gen. Mang.













MDRX Stock - Frequently Asked Questions

Should I buy or sell Allscripts Healthcare Solutions stock right now?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Allscripts Healthcare Solutions in the last year. There are currently 4 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" MDRX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MDRX, but not buy additional shares or sell existing shares.
View MDRX analyst ratings
or view top-rated stocks.

What is Allscripts Healthcare Solutions' stock price forecast for 2022?

6 brokers have issued twelve-month price targets for Allscripts Healthcare Solutions' stock. Their MDRX share price forecasts range from $17.00 to $26.00. On average, they expect the company's share price to reach $22.00 in the next year. This suggests a possible upside of 32.0% from the stock's current price.
View analysts price targets for MDRX
or view top-rated stocks among Wall Street analysts.

How have MDRX shares performed in 2022?

Allscripts Healthcare Solutions' stock was trading at $18.45 at the beginning of the year. Since then, MDRX stock has decreased by 9.6% and is now trading at $16.67.
View the best growth stocks for 2022 here
.

When is Allscripts Healthcare Solutions' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 3rd 2022.
View our MDRX earnings forecast
.

How were Allscripts Healthcare Solutions' earnings last quarter?

Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) announced its earnings results on Thursday, August, 4th. The software maker reported $0.18 earnings per share for the quarter, topping analysts' consensus estimates of $0.15 by $0.03. The software maker had revenue of $150.90 million for the quarter, compared to the consensus estimate of $148.58 million. Allscripts Healthcare Solutions had a net margin of 5.90% and a trailing twelve-month return on equity of 10.62%. The business's revenue for the quarter was up 6.9% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.17 earnings per share.

How will Allscripts Healthcare Solutions' stock buyback program work?

Allscripts Healthcare Solutions declared that its board has authorized a stock repurchase program on Wednesday, May 26th 2021, which authorizes the company to repurchase $350,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to repurchase up to 14% of its shares through open market purchases. Shares repurchase programs are typically an indication that the company's management believes its shares are undervalued.

What is Paul Black's approval rating as Allscripts Healthcare Solutions' CEO?

796 employees have rated Allscripts Healthcare Solutions Chief Executive Officer Paul Black on Glassdoor.com. Paul Black has an approval rating of 65% among the company's employees.

What other stocks do shareholders of Allscripts Healthcare Solutions own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Allscripts Healthcare Solutions investors own include Advanced Micro Devices (AMD), Netflix (NFLX), Energy Transfer (ET), CVS Health (CVS), Ford Motor (F), Himax Technologies (HIMX), Intel (INTC), OPKO Health (OPK), Tesla (TSLA) and Activision Blizzard (ATVI).

What is Allscripts Healthcare Solutions' stock symbol?

Allscripts Healthcare Solutions trades on the NASDAQ under the ticker symbol "MDRX."

Who are Allscripts Healthcare Solutions' major shareholders?

Allscripts Healthcare Solutions' stock is owned by a variety of institutional and retail investors. Top institutional investors include State Street Corp (3.84%), Goldman Sachs Group Inc. (2.58%), Millennium Management LLC (2.24%), JPMorgan Chase & Co. (2.09%), Northern Trust Corp (1.58%) and Loomis Sayles & Co. L P (1.32%). Insiders that own company stock include Brian Farley, Dennis Olis, Elaina Shekhter, Elizabeth Ann Altman, Greg Garrison, Leah Jones, Lisa Khorey, Michael Klayko, Paul Black, Richard J Poulton and Thomas Langan.
View institutional ownership trends
.

How do I buy shares of Allscripts Healthcare Solutions?

Shares of MDRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Allscripts Healthcare Solutions' stock price today?

One share of MDRX stock can currently be purchased for approximately $16.67.

How much money does Allscripts Healthcare Solutions make?

Allscripts Healthcare Solutions (NASDAQ:MDRX) has a market capitalization of $1.85 billion and generates $1.50 billion in revenue each year. The software maker earns $134.44 million in net income (profit) each year or $0.43 on an earnings per share basis.

How many employees does Allscripts Healthcare Solutions have?

The company employs 8,000 workers across the globe.

Does Allscripts Healthcare Solutions have any subsidiaries?
The following companies are subsidiares of Allscripts Healthcare Solutions: HealthGrid, Practice Fusion, and ZappRx.
Read More
How can I contact Allscripts Healthcare Solutions?

Allscripts Healthcare Solutions' mailing address is 222 MERCHANDISE MART PLAZA SUITE 2024, CHICAGO IL, 60654. The official website for the company is www.allscripts.com. The software maker can be reached via phone at (800) 334-8534, via email at stephen.shulstein@allscripts.com, or via fax at 313-322-9600.

This page (NASDAQ:MDRX) was last updated on 9/24/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.